. Shows the densitometry analysis of EMT markers expression in CRPC cells. Quiescent C4-2B, DU145, and PC3 cells were left untreated or treated for 72h with the indicated compounds. NGF was used at 100ng/mL and GW441756 (GW) at 1 μM. Lysate proteins were analyzed by Western blot, using the antibodies against E-cadherin or vimentin. The blots from three different experiments were done and expression levels of E-cadherin and vimentin were analyzed by densitometry, using NIH Image J Software. For each experiment, the ratio E-cadherin/tubulin in C4-2B (A), DU145 (C) and PC3 (E) cells and the ratio vimentin/tubulin in C4-2B (B), DU145 (D) and PC3 (F) cells was evaluated.
Results were expressed as fold change. Means and SEMs are shown, n represents the number of the experiments. *: p < 0,05 for the indicated experimental points versus the corresponding untreated control. Figure S4 . Shows the densitometry analysis of ERK and Akt activation in CRPC cells. Quiescent C4-2B, DU145 and PC3 cells were used. Cells were left un-stimulated or stimulated with 100 ng/mL NGF. Lysate proteins were analyzed by Western blot, using the anti p-ERK (P-Tyr 204 ERK 1 and the corresponding phosphorylated ERK 2) or anti p-Akt (P-Ser 473 Akt) antibodies. Filters were re-probed using anti ERK or anti Akt antibodies, as a loading control. Densitometry analysis from 3 different experiments was done using NIH Image J Software. For each experiment, the ratio p-ERK/ERK in C4-2B (A), DU145 (C) and PC3 (E) cells and the ratio p-Akt/Akt in C4-2B (B), DU145 (D) and PC3 (F) cells were evaluated and results expressed as fold change. Means and SEMs are shown, n represents the number of the experiments.
